Abnormal body iron distribution and erythropoiesis in a novel mouse model with inducible gain of iron regulatory protein (IRP)-1 function

Abnormal body iron distribution and erythropoiesis in a novel mouse model with inducible gain of iron regulatory protein (IRP)-1 function. D. Casarrubea, L. Viatte, T. Hallas, A. Vasanthakumar, R. S. Eisenstein, K. Schümann, M. W. Hentze and B. Galy. J Mol Med (Berl). 2013 July; 91(7): 871–881. Published online 2013 March 1. doi: 10.1007/s00109-013-1008-2

It opens novel avenues to study diseases associated with abnormally high IRP1 activity, such as Parkinson’s disease or Friedreich’s ataxia.

Insights into the role of oxidative stress in the pathology of Friedreich Ataxia using peroxidation resistant polyunsaturated fatty acids

Insights into the role of oxidative stress in the pathology of Friedreich Ataxia using peroxidation resistant polyunsaturated fatty acids. M.Grazia Cotticelli, Andrew M. Crabbe, Robert B. Wilson, Mikhail S. Shchepinov; Redox Biology, Available online 19 July 2013. DOI: http://dx.doi.org/10.1016/j.redox.2013.06.004

Open Access Article

FULL TEXT PDF

Clinical features of Friedreich's ataxia: classical and atypical phenotypes

Clinical features of Friedreich's ataxia: classical and atypical phenotypes. Michael H. Parkinson, Sylvia Boesch, Wolfgang Nachbauer, Caterina Mariotti, Paola Giunti. J. Neurochem.(2013) 126 (Suppl. 1), 103–117. DOI: 10.1111/jnc.12317

FULL TEXT PDF

Increasing frataxin gene expression with histone deacetylase inhibitors as a therapeutic approach for Friedreich's ataxia

Increasing frataxin gene expression with histone deacetylase inhibitors as a therapeutic approach for Friedreich's ataxia. Joel M. Gottesfeld, James R. Rusche and Massimo Pandolfo. J. Neurochem.(2013) 126 (Suppl. 1), 147–154. DOI: 10.1111/jnc.12302

FULL TEXT PDF

Cardiomyopathy of Friedreich Ataxia

Cardiomyopathy of Friedreich Ataxia Frank Weidemann, Stefan Störk, Dan Liu, Kai Hu, Sebastian Herrmann, Georg Ertl and Markus Niemann. J. Neurochem.(2013) 126 (Suppl. 1), 88–93. DOI: 10.1111/jnc.12217

FULL TEXT PDF

Erythropoietin in Friedreich ataxia

Erythropoietin in Friedreich ataxia. Caterina Mariotti, Wolfgang Nachbauer, Marta Panzeri, Werner Poewe, Franco Taroni and Sylvia Boesch. J. Neurochem.(2013) 126 (Suppl. 1), 80–87. DOI: 10.1111/jnc.12301

FULL TEXT PDF

Animal and cellular models of Friedreich ataxia

Animal and cellular models of Friedreich ataxia. Morgane Perdomini, Aurore Hick, Hélène Puccio and Mark A. Pook. J. Neurochem.(2013) 126 (Suppl. 1), 65–79. DOI: 10.1111/jnc.12219

FULL TEXT PDF

Frataxin: a protein in search for a function

Frataxin: a protein in search for a function. Annalisa Pastore and Helene Puccio; J. Neurochem.(2013) 126 (Suppl. 1), 43–52. DOI: 10.1111/jnc.12220

FULL TEXT PDF

Gene regulation and epigenetics in Friedreich's ataxia

Gene regulation and epigenetics in Friedreich's ataxia. Cihangir Yandim, Theona Natisvili and Richard Festenstein. J. Neurochem.(2013) 126 (Suppl. 1), 21–42. DOI: 10.1111/jnc.12254

FULL TEXT PDF

Prevalence gradients of Friedreich's Ataxia and R1b haplotype in Europe co-localize, suggesting a common Palaeolithic origin in the Franco-Cantabrian ice age refuge

Prevalence gradients of Friedreich's Ataxia and R1b haplotype in Europe co-localize, suggesting a common Palaeolithic origin in the Franco-Cantabrian ice age refuge. Pierre Vankan; J. Neurochem.(2013) 126 (Suppl. 1), 11–20. DOI: 10.1111/jnc.12215

FULL TEXT PDF